MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Phase III Radium 223 mCRPC-PEACE III

Phase 3
Active, not recruiting
Conditions
Prostate Cancer
Interventions
First Posted Date
2014-07-18
Last Posted Date
2024-04-05
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
446
Registration Number
NCT02194842
Locations
🇮🇹

Ospedale B.Ramazzini, Carpi, Italy

🇨🇦

Hamilton And District Urology Association, Hamilton, Ontario, Canada

🇨🇦

London Regional Cancer Center, London, Ontario, Canada

and more 61 locations

"InDACtion" vs "3+7" Induction in AML

Phase 3
Active, not recruiting
Conditions
Acute Myeloid Leukemia (AML)
Interventions
Drug: standard combination chemotherapy
First Posted Date
2014-06-24
Last Posted Date
2023-02-15
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
606
Registration Number
NCT02172872
Locations
🇩🇪

Klinikum Augsburg, Augsburg, Germany

🇩🇪

Universitaet Rostock - Medizinische Fakultaet, Rostock, Germany

🇩🇪

Klinikum Der Phillips - Universität Marburg, Marburg, Germany

and more 50 locations

IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

Phase 2
Active, not recruiting
Conditions
Uterine Sarcoma
Interventions
Drug: Placebo
First Posted Date
2013-11-08
Last Posted Date
2024-02-06
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
58
Registration Number
NCT01979393
Locations
🇳🇱

Academisch Medisch Centrum at University of Amsterdam, Amsterdam, Netherlands

🇫🇷

Centre Leon Berard, Lyon, France

🇪🇸

Hospital Universitario San Carlos, Madrid, Spain

and more 11 locations

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

First Posted Date
2013-10-25
Last Posted Date
2024-11-05
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
149
Registration Number
NCT01969578
Locations
🇮🇹

Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy

🇮🇹

Azienda Provinciale per i Servizi Sanitari - Ospedale Santa Chiara, Trento, Italy

🇦🇹

Medical University Vienna - General Hospital AKH, Vienna, Austria

and more 23 locations

Minimal SN Tumor Burden

Active, not recruiting
Conditions
Cutaneous Melanoma
First Posted Date
2013-09-16
Last Posted Date
2023-11-28
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
296
Registration Number
NCT01942603
Locations
🇬🇧

Norfolk And Norwich Hospital, Norwich, United Kingdom

🇮🇹

Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Napoli, Italy

🇳🇱

Erasmus MC Cancer Institute - location Daniel den Hoed, Rotterdam, Netherlands

and more 19 locations

Ph II Cabazitaxel DD Liposarcoma

Phase 2
Completed
Conditions
Dedifferentiated Liposarcoma
Interventions
First Posted Date
2013-08-01
Last Posted Date
2021-09-14
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
42
Registration Number
NCT01913652
Locations
🇧🇪

Universitair Ziekenhuis Antwerpen (117), Antwerpen, Belgium

🇮🇹

Istituto Oncologico Veneto IRCCS - Ospedale Busonera (3908), Padova, Italy

🇫🇷

Centre Leon Berard (227), Lyon, France

and more 8 locations

Cancer in Nursing Home Residents

Completed
Conditions
Armonea Nursing Homes Residents
First Posted Date
2013-07-29
Last Posted Date
2019-03-13
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
125
Registration Number
NCT01910376
Locations
🇧🇪

Armonea nursing homes network, Mechelen, Belgium

AF CRT +/- Nimorazole in HNSCC

Phase 3
Conditions
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
Interventions
Radiation: Radiotherapy
Drug: Placebo
First Posted Date
2013-06-19
Last Posted Date
2022-05-10
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
640
Registration Number
NCT01880359
Locations
🇳🇱

Radboud University Medical Center Nijmegen, Nijmegen, Netherlands

🇦🇺

Princess Alexandra Hospital - University Of Queensland, Brisbane, Australia

🇩🇪

Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany

and more 16 locations

Genetics of EGFR (Epidermal Growth Factor Receptor) Mutation Study

Conditions
EGFR Mutation Positive Non Small Cell Lung Cancer
First Posted Date
2013-04-24
Last Posted Date
2021-03-09
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
2000
Registration Number
NCT01838577
Locations
🇬🇧

Royal Marsden, Sutton, United Kingdom

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Phase 3
Completed
Conditions
Neoplasm, Prostate
Interventions
Procedure: Immediate Orchiectomy or depot LHRH
Procedure: Delayed Orchiectomy or depot LHRH
First Posted Date
2013-03-27
Last Posted Date
2013-03-27
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
985
Registration Number
NCT01819285
© Copyright 2025. All Rights Reserved by MedPath